Knopp Biosciences

Developer of small-molecule therapeutics for the treatment of CNS and inflammatory diseases

placePittsburgh, Pennsylvania, United States calendar_todayFounded 2005 groups23 employees language knoppbio.com

Registered entities

Innovation

22 patent families (15 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 10,017 times.

YearFilings
20143
20155
201613
201711
20188
201910
20209
20219
20225
20234
20242
20251

Investor mix

9 investors on record; lead investors include Saturn Partners, Kramer Capital Partners, LaunchCyte, Innovation Works.

Investor typeCountShare
Venture capital778%
Other / undisclosed222%
Coming soon